Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-03-15Influence of Respiratory Training on Functional Capacity in Patients With Leukemia
-
CLINICAL_TRIALS study record update · 2019-02-27A PHASE I TRIAL OF SUBCUTANEOUS, OUTPATIENT INTERLEUKIN-2 FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
-
CLINICAL_TRIALS study record update · 2019-02-27Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath-1H for Previously Treated Relapsed or Refractory Patients With Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2019-02-25Treatment of Elderly Relapsed and/or Refractory CD19-positive Acute Lymphoblastic Leukemia by Infusions of Allogeneic CART-19
-
CLINICAL_TRIALS study record update · 2019-02-15Phase II Study of Adult Acute Lymphoblastic Leukaemia (ALL): Imatinib in Combination With Chemotherapy in Ph+ Patients, and Post-remissional Treatment Intensification in High-risk Ph- Patients, With Minimal Residual Disease Monitoring.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-02-12Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers
-
CLINICAL_TRIALS study record update · 2019-02-04A Phase I-II Study of Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2019-01-11A Phase I Trial of Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab
-
CLINICAL_TRIALS study record update · 2019-01-09CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2018-12-31Allogeneic HSCT Without Preparative Chemotherapy or With Low-Intensity Preparative Chemotherapy Using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2018-12-19Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter Associated Bloodstream Infection: Impact on Length of Stay and Catheter Salvage
-
CLINICAL_TRIALS study record update · 2018-12-13Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy
-
CLINICAL_TRIALS study record update · 2018-12-03CD19-directed Chimeric Antigen Receptor T Cells Therapy in Relapsed/Refractory B Cell Malignancy
-
CLINICAL_TRIALS study record update · 2018-11-20A Phase II Study of the Novel Proteasome Inhibitor Bortezomib in Combination With Rituximab, Cyclophosphamide and Prednisone in Patients With Relapsed/Refractory Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
-
CLINICAL_TRIALS study record update · 2018-11-19A Phase 2 Study of LY2090314 in Participants With Acute Leukemia
-
CLINICAL_TRIALS study record update · 2018-11-15Phase I/II Study of 5-aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2018-11-14Arsenic Trioxide Therapy for Interferon Alpha Refractory or Intolerant Chronic Phase Chronic Myelogenous Leukemia
-
CLINICAL_TRIALS study record update · 2018-11-14Phase II Study of a Proteasome Inhibitor, PS-341 (NSC 681239) in Chronic Myelogenous Leukemia (CML) in Chronic or Accelerated Phase
-
CLINICAL_TRIALS study record update · 2018-11-13A Randomized Phase II Trial of Interferon + GM-CSF Versus K562/GM-CSF Vaccination in CML Patients Achieving a Complete Cytogenetic Response to Frontline Tyrosine Kinase Inhibitor Therapy
-
CLINICAL_TRIALS study record update · 2018-11-08A Pilot Trial of GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2018-11-05Phase II Study of High Dose Cyclophosphamide and Rituximab in Low Grade and Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2018-11-02New York Blood Center National Cord Blood Program
-
CLINICAL_TRIALS study record update · 2018-11-02First-Line Dasatinib or Nilotinib Followed by Response Guided Switch to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2018-10-31Allogeneic Stem Cell Transplantation Using Mylotarg (CMA-676) Plus Nonmyeloablative Chemotherapy in Older or Medically Infirm Patients With High-Risk Acute Leukemia (ALL), Chronic Myelogenous Leukemia (CML) or Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2018-10-31Phase II Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies